Clinical Trials Browser

Interventional × Bone Diseases, Metabolic × Breast × Clear all

NCT07334626 2026-01-15

PilatesBCS2026

Phase NA Recruiting

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis

NCT01623908 2021-06-22

BLAZE

Phase NA Terminated

Bone Diseases, Metabolic, Breast Neoplasms

NCT03518268 2019-01-17

Vivomixx for Prevention of Bone Loss in Women With Breast Cancer Treated With an Aromatase Inhibitor

Phase 1/2 Unknown

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis

NCT00089661 2018-10-17

AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer

Phase 3 Completed

252 enrolled 13 charts

Bone Diseases, Metabolic, Breast Neoplasms

NCT00485953 2017-10-13

REBBeCA II

Phase 4 Completed

109 enrolled 11 charts

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis

NCT01105923 2015-02-02

MAPLE

Phase NA Unknown

BreastClassical hematologyHead & Neck

Anemia, Sickle Cell, Asthma, Attention Deficit Disorder with Hyperactivity, Bone Diseases, Metabolic, Breast Neoplasms, Coronary Artery Disease, Diabetes Mellitus, Glaucoma, Heart Failure, Hemophilia A, Hypertension, Hyperthyroidism, Hypothyroidism, Myasthenia Gravis, Osteoporosis, Stroke, Pulmonary Disease, Chronic Obstructive, Renal Insufficiency

NCT00859703 2013-10-31

RISAROS

Phase 3 Completed

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis

NCT00766532 2012-09-14

Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption?

Phase 4 Completed

12 enrolled 5 charts

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis, Fractures, Bone

NCT00171340 2012-04-16

Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.

Phase 3 Completed

1,065 enrolled 10 charts

Bone Diseases, Metabolic, Breast Neoplasms

NCT00082277 2011-01-26

SABRE

Phase 4 Completed

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis